AttendMe Owl Logo
AttendMe
Evidence Evolution
Emergency MedicineEmergency Medicine

How This Evidence Evolved

Opioid-Sparing ED Analgesia

Ending the opioid-first culture in acute pain management

6.5

Timeline

Motov 2015
2015
Motov 2017
2017
Chang 2017
2017
CDC Opioid Prescribing Guideline 2022
2022
Trial
Guideline
Approval
Meta-analysis
Signal

Early observations and pilot data that first suggested a new direction

Trials tested opioid-sparing options for selected ED patients. Motov compared IV ketamine 0.3 mg/kg with morphine 0.1 mg/kg in adults with acute abdominal, flank or musculoskeletal pain. Chang compared single-dose ibuprofen/acetaminophen with three opioid/acetaminophen combinations for acute extremity pain; pain reduction at two hours did not differ significantly or clinically.
Proof

Landmark RCTs and pivotal trials that established the evidence base

Motov compared ketamine 0.3 mg/kg IV with morphine 0.1 mg/kg in 45 patients per arm, finding similar short-term analgesia. The ketorolac trial found no pain-reduction difference among 10, 15 and 30 mg IV doses in 240 patients. Chang randomized 416 patients with acute extremity pain to ibuprofen/acetaminophen or three opioid/acetaminophen combinations. Pain reduction at 2 hours did not differ significantly or clinically; this was not a formal noninferiority result. Adverse events were not assessed in that trial.
Guidelines

Integration into clinical practice guidelines and recommendations

CDC 2022 covers adult outpatients, excluding SCD/cancer pain and palliative/end-of-life care. Maximize nonopioid therapies as appropriate for acute pain; consider opioids only if benefits outweigh risks, for no longer than pain severe enough to require them.
CDC Clinical Practice Guideline for Prescribing Opioids

For adult outpatient acute pain, maximize suitable nonopioid therapies; opioids only if benefits outweigh risks.

Now

Current standard of care and ongoing research directions

Trials tested ketamine, ketorolac and ibuprofen/acetaminophen in selected ED patients. The challenge remains implementing these consistently across diverse ED settings and pain presentations.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

Are non-opioid painkillers as effective as opioids in the emergency department?+
Chang randomized 416 patients with acute extremity pain. Single-dose ibuprofen/acetaminophen and three opioid combinations had no statistically significant or clinically important pain-reduction differences at 2 hours; adverse events were not assessed. Motov found comparable short-term analgesia with low-dose IV ketamine and morphine.
What is subdissociative-dose ketamine and how is it used for pain?+
Subdissociative intravenous ketamine at 0.3 mg/kg provided analgesia comparable to morphine 0.1 mg/kg for short-term acute pain treatment in the ED. The ketamine group reported more minor adverse effects at 15 minutes. No serious adverse events occurred in either group.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026